News
InfuSystem Reports First Quarter 2022 Financial Results
Signed 3-year Master Service Agreement with Leading Global Medical Technology and Diagnostic Company - Estimated Potential Annual Revenue of $10 Million to $12 Million Revenue Growth of 9% - Driven by 18% Growth in DME and 5% in ITS Strong Operating Cash Flow Growth...
InfuSystem Announces Master Service Agreement with Leading Global Healthcare Technology and Diagnostic Company
Preferred National Service Agreement to provide service and repair to fleet of more than 300,000 pumps in North America; Estimated $10-$12 million of annual revenue ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the...
InfuSystem to Report First Quarter 2022 Financial Results on May 5, 2022
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block Catheters
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the "Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today...
InfuSystem Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2021
Full Year 2021 vs. Full Year 2020: Net Revenues: $102.4 million, a 5% increase Net Income: $1.4 million, Adjusted EBITDA: $24.0 million ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU), ("InfuSystem" or the "Company"), a leading national health...
InfuSystem to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on February 10, 2022
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem to Present at Sidoti Winter Virtual Investor Conference on Wednesday, January 19, 2022
Investor Presentation to be held at 8:30 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Reports Third Quarter 2021 Financial Results
Selected as Supplier of Infusion Pump Biomedical Services for Leading Global Medical Technology and Diagnostic Equipment Company Worth Expected $14 Million to $15 Million in Annual Revenue Potential Received Pain Management Service Agreement with Leading U.S....
InfuSystem to Report Third Quarter 2021 Financial Results on November 15, 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Announces Pain Management Service Agreement with Leading U.S. Health Care Provider
Exclusive 3-year agreement providing electronic infusion pumps to treat post-surgical pain ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating...